GNUV201, a novel human/mouse cross-reactive and low pH-selective anti-PD-1 monoclonal antibody for cancer immunotherapy
Article in BMC Immunology (May 2024)
The most recent citing publications are shown below. View all 41 publications that cite this research output on Dimensions.
Article in BMC Immunology (May 2024)
Preprint in bioRxiv (May 2024)
Article in Journal for ImmunoTherapy of Cancer (March 2024)